Amount | Description | |
---|---|---|
Performance shares | Performance sharesAmount
|
Performance sharesDescription
Concerning the granting of performance shares in 2023, the Board of Directors will be called upon to decide on the implementation of a new Plan within the scope of the authorisation approved by the Annual General Meeting on 21 April 2022. The grant that would be decided for Mr Nicolas Hieronimus would comply with the recommendations of the AFEP-MEDEF Code. The value of the grant (estimated according to the IFRS standards), represents approximately 50% of the executive corporate officer’s total remuneration without exceeding 60%. Mr Nicolas Hieronimus is also required to hold 50% of the free shares that are fully vested to him at the end of the vesting period in registered form until the termination of his term of corporate office. Final vesting of these shares is subject to achievement of performance conditions which will be recorded at the end of a 4-year vesting period as from the grant date. The number of vested shares would depend:
The calculation will be based on the arithmetical average for the three full financial years of the vesting period. The first full year taken into account for assessment of the performance conditions relating to this grant would be 2024. Details of the conditional vesting thresholds are given on page 97. |
Remuneration as Director | Remuneration as DirectorAmount €0 |
Remuneration as DirectorDescription Mr Nicolas Hieronimus will not receive remuneration for his position as Director. |
Benefits in addition to remuneration | Benefits in addition to remunerationAmount
|
Benefits in addition to remunerationDescription
Mr Nicolas Hieronimus will benefit from the material resources needed for the performance of his office such as, for example, the provision of a car with a driver. These arrangements, which are strictly limited to professional use, to the exclusion of all private use, are not benefits in kind.
Mr Nicolas Hieronimus will continue to be treated in the same way as a senior manager during the term of his corporate office, which will allow him to continue to benefit from the additional social protection schemes and, in particular, the defined contribution pension scheme, and the employee benefit and healthcare schemes applicable to the Company’s employees. The amount of the pension resulting from the employer’s contributions for the defined contribution pension scheme will be deducted from the pension due in respect of the defined benefit pension in accordance with the provisions of this collective scheme. |
The Board of Directors, in accordance with the recommendation of the AFEP-MEDEF Code (Article 25-2), is proposing to the Annual General Meeting of 21 April 2023 that the exercise of the office of Chairman of the Board of Directors without assuming the office of Chief Executive Officer, would be remunerated only by fixed remuneration, excluding any variable remuneration, grant of performance shares and any indemnity related to departure or any consideration for a non-compete agreement.
The Board of Directors also decided that the tenure as Director held by the Chairman of the Board would not be remunerated.
The Chairman of the Board will benefit from the necessary material resources for the performance of his office such as, for example, the provision of a car with a driver. These arrangements, which are strictly limited to professional use, are not benefits in kind.
The Chairman of the Board will benefit from the same employee benefit scheme as the senior managers of the Company.
The remuneration of the Chairman of the Board of Directors is determined based on the following components:
(1) A site can claim “carbon neutral” status if it meets the following requirements: